AlivaMab Discovery Service LLC is a trusted partner for top-tier pharmaceutical and biotechnology companies, offering antibody discovery and engineering technologies. With a team of experienced professionals from leading pharmaceutical companies, AlivaMab delivers fully human antibodies on exceptional timelines, characterized for function and developability. Their mission is to empower partners with an efficient and de-risked path through therapeutic antibody discovery and development, ultimately contributing to a healthier world through better medicines for patients.
Using trusted technologies and platforms, such as the Ablexis AlivaMab Mouse, AlivaMab Biologics ensures the highest probability of success in their more than 500 discovery programs and 35 clinical candidates. They offer downstream capabilities in antibody engineering for advanced modalities, including multispecifics and CARs, providing comprehensive solutions for their partners' antibody discovery programs.
Generated from the website
